Clinical Proof of Concept (POC) of Glucokinase Activator HMS5552 Achieved in Chinese T2DM Patients: HbA1c Reduction of 1.22% with 100% Response Rate and Improved β-cell Function
2016 ADA Poster
Online link unavailable, presentation available upon request. (BD@huamedicine.com)
搜索
